Edesa Biotech Inc (EDSA) Hedge Fund Ownership (Q1 2026)

Q: Is it too late to buy Edesa Biotech Inc (EDSA) following the 2026 Q2 hedge fund 13F filings?

As of today, EDSA has moved +12.1% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.1% for the XLV sector ETF — an outperformance of +12.0%. Since the quarter end (June 30, 2026), EDSA gained -26.2% vs +5.6% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Edesa Biotech Inc (EDSA)

26 + Investors. Track Smart Money conviction in EDSA. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — EDSA

Based on 26 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q

For 1 consecutive quarter, more hedge funds added EDSA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

26 hedge funds hold EDSA right now — the highest count in 2.5 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +44% more funds vs a year ago

fund count last 6Q

+8 new funds entered over the past year (+44% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 61% buying

19 buying12 selling

Last quarter: 19 funds were net buyers (15 opened a brand new position + 4 added to an existing one). Only 12 were sellers (2 trimmed + 10 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+9 vs last Q)

new funds entering per quarter

Funds opening a new EDSA position: 4 → 6 → 6 → 15. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔄

Mostly new holders — 58% entered in last year

■ 19% conviction (2yr+) ■ 23% medium ■ 58% new

Only 5 funds (19%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💰

Price up while funds trimmed (+215% value, -13% shares)

Value

+215%

-13%

Last quarter: total value of institutional EDSA holdings rose +215% even though funds reduced share count by 13%. The stock price increased enough to offset the selling. Institutions are quietly trimming into price strength — watch for rotation.

📈

Growing discovery — still being found

7 → 4 → 6 → 6 → 15 new funds/Q

New funds entering each quarter: 4 → 6 → 6 → 15. A growing number of institutions are discovering EDSA each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🌱

Early stage — 77% of holders entered in last year

■ 23% veterans ■ 0% 1-2yr ■ 77% new

Of 26 current holders: 20 (77%) entered in the past year, only 6 (23%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

📋

Smaller funds dominant — 6% AUM from top-100

6% from top-100 AUM funds

7 of 26 holders rank in the top 100 by AUM, but together hold only 6% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

4.8

out of 10

Moderate Exit Risk

Exit risk score 4.8/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	26	20	30.0%
13F Shares	3M	3M	-13.4%
Total Value	$14M	$4M	215.48%
New Positions	15	6	+9
Increased Positions	4	4	-
Closed Positions	9	7	+2
Reduced Positions	2	3	-1
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

30.0%

13F Shares

-13.4%

Total Value

$14M

$4M

215.48%

New Positions

Increased Positions

Closed Positions

Reduced Positions

-1

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

26 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in EDSA. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 EDSA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Velan Capital Investment Management LP	4.10%	827,500	$6.7M
2	Stonepine Capital Management, LLC	1.49%	456,439	$3.2M
3	Boxer Capital Management, LLC	0.13%	205,000	$1.7M
4	Perceptive Advisors LLC	0.07%	563,239	$4.6M
5	Rubric Capital Management LP	0.05%	669,500	$5.4M
6	Mcguire Capital Advisors Inc	0.01%	1,500	$12K
7	XTX Topco Ltd	0.00%	35,352	$287K
8	Millennium Management LLC	0.00%	561,751	$4.6M
9	SBI Securities Co., Ltd.	0.00%	3,505	$28K
10	Hrt Financial LP	0.00%	31,531	$256K
11	Scotia Capital INC.	0.00%	14,393	$117K
12	Tower Research Capital LLC (TRC)	0.00%	1,230	$10K
13	Two Sigma Investments, LP	0.00%	14,032	$114K
14	Vanguard Fiduciary Trust Co	0.00%	38,718	$315K
15	Federation des caisses Desjardins du Quebec	0.00%	2,595	$21K
16	Jane Street Group, LLC	0.00%	72,465	$589K
17	Vanguard Capital Management LLC	0.00%	81,839	$665K
18	UBS Group AG	0.00%	6,763	$55K
19	BlackRock, Inc.	0.00%	27,495	$224K
20	BNP Paribas Financial Markets	0.00%	1,122	$9K
21	TD Waterhouse Canada Inc.	0.00%	142	$1K
22	Royal Bank of Canada	0.00%	1,851	$15K
23	LRI Investments, LLC	0.00%	1	—
24	Morgan Stanley	0.00%	1,400	$11K
25	Jpmorgan Chase & Co	0.00%	1,130	$9K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Edesa Biotech Inc (EDSA)

What does the Smart Money Trend signal show for EDSA?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added EDSA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for EDSA?

More buyers than sellers — 61% buying: Last quarter: 19 funds were net buyers (15 opened a brand new position + 4 added to an existing one). Only 12 were sellers (2 trimmed + 10 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for EDSA holders?

Smaller funds dominant — 6% AUM from top-100: 7 of 26 holders rank in the top 100 by AUM, but together hold only 6% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held EDSA?

Mostly new holders — 58% entered in last year: Only 5 funds (19%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Edesa Biotech Inc (EDSA) following the 2026 Q2 hedge fund 13F filings?

As of today, EDSA has moved +12.1% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.1% for the XLV sector ETF — an outperformance of +12.0%. Since the quarter end (June 30, 2026), EDSA has gained -26.2% vs +5.6% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Edesa Biotech Inc (EDSA)

Smart Money Signals — EDSA

Buying streak — 1 quarter in a row

At the ownership peak (100% of max)

Fast accumulation — +44% more funds vs a year ago

More buyers than sellers — 61% buying

More new buyers each quarter (+9 vs last Q)

Mostly new holders — 58% entered in last year

Price up while funds trimmed (+215% value, -13% shares)

Growing discovery — still being found

Early stage — 77% of holders entered in last year

Smaller funds dominant — 6% AUM from top-100

Institutional Sentiment Summary — EDSA

Hedge Fund Ownership: EDSA

Market Analysis: EDSA

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: EDSA

Is It Too Late to Buy Edesa Biotech Inc (EDSA) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: EDSA

Statistics: EDSA

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Edesa Biotech Inc (EDSA)

Welcome to 13Foresight!